SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BONDANELLI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.889
AS - Asia 7.205
EU - Europa 4.914
SA - Sud America 1.104
Continente sconosciuto - Info sul continente non disponibili 201
AF - Africa 154
OC - Oceania 13
Totale 25.480
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.500
SG - Singapore 2.720
CN - Cina 1.826
DE - Germania 1.455
IT - Italia 938
BR - Brasile 875
VN - Vietnam 730
UA - Ucraina 693
HK - Hong Kong 602
GB - Regno Unito 373
RU - Federazione Russa 344
TR - Turchia 335
FI - Finlandia 289
BD - Bangladesh 271
FR - Francia 262
JP - Giappone 184
CA - Canada 174
PL - Polonia 159
SE - Svezia 153
IN - India 148
MX - Messico 132
AR - Argentina 78
ID - Indonesia 74
IQ - Iraq 58
NL - Olanda 58
ZA - Sudafrica 56
PK - Pakistan 50
EC - Ecuador 44
ES - Italia 40
VE - Venezuela 30
CO - Colombia 27
BE - Belgio 26
MY - Malesia 24
SA - Arabia Saudita 22
LT - Lituania 20
UZ - Uzbekistan 20
MA - Marocco 19
TN - Tunisia 19
AE - Emirati Arabi Uniti 17
PH - Filippine 17
AT - Austria 16
CL - Cile 16
JM - Giamaica 16
AU - Australia 13
IE - Irlanda 12
JO - Giordania 11
AL - Albania 10
BO - Bolivia 10
CR - Costa Rica 10
PY - Paraguay 10
TH - Thailandia 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
DK - Danimarca 8
EG - Egitto 8
KE - Kenya 8
LB - Libano 8
PA - Panama 8
PS - Palestinian Territory 8
RO - Romania 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
ET - Etiopia 7
IL - Israele 7
KR - Corea 7
KZ - Kazakistan 7
SV - El Salvador 7
UY - Uruguay 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
PE - Perù 6
HN - Honduras 5
KG - Kirghizistan 5
LV - Lettonia 5
NP - Nepal 5
BB - Barbados 4
CY - Cipro 4
GA - Gabon 4
GT - Guatemala 4
IR - Iran 4
NG - Nigeria 4
NI - Nicaragua 4
PR - Porto Rico 4
AO - Angola 3
BF - Burkina Faso 3
BG - Bulgaria 3
BH - Bahrain 3
GR - Grecia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TZ - Tanzania 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
EU - Europa 2
GP - Guadalupe 2
KH - Cambogia 2
Totale 25.243
Salva come PNG Salva come JPEG
Città #
Singapore 1.730
Ashburn 1.317
San Jose 978
Woodbridge 905
Chandler 722
Jacksonville 681
Fairfield 604
Santa Clara 596
Hong Kong 591
Beijing 587
Houston 420
Ann Arbor 342
Wilmington 278
New York 270
Ho Chi Minh City 242
Los Angeles 231
Council Bluffs 227
Seattle 223
Izmir 207
Nanjing 203
Addison 202
Cambridge 183
Dallas 176
Munich 176
Tokyo 174
Hanoi 172
Milan 171
Princeton 155
Warsaw 152
Lauterbourg 139
Helsinki 111
San Diego 97
Shanghai 91
São Paulo 91
Mexico City 79
Shenyang 70
Boardman 66
Ferrara 65
Orem 58
Hebei 56
Hefei 55
Buffalo 54
Montreal 52
Toronto 51
Dearborn 50
London 50
Chicago 47
Turku 47
Nanchang 46
Rome 45
Tianjin 45
Phoenix 44
Chennai 40
Bremen 39
Changsha 38
Denver 38
Haiphong 38
Jakarta 37
Brooklyn 34
Bologna 33
Moscow 31
San Francisco 31
Jiaxing 30
Johannesburg 30
Manchester 29
Poplar 29
Stockholm 29
Da Nang 28
Washington 28
Atlanta 27
Kunming 27
Baghdad 25
Falls Church 25
Frankfurt am Main 25
Rio de Janeiro 25
Boston 24
Brussels 24
Jinan 24
Redwood City 24
Mountain View 23
Mumbai 23
Hải Dương 21
Norwalk 21
Quito 21
Amsterdam 20
Lahore 20
Naples 20
Belo Horizonte 19
Zhengzhou 19
Guangzhou 18
Curitiba 17
Philadelphia 17
Tashkent 17
Ankara 16
Falkenstein 16
Brasília 15
Campinas 15
Charlotte 15
Ningbo 15
Dhaka 14
Totale 15.618
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 330
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 291
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 269
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 259
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 259
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 247
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 245
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 239
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 231
Acromegaly is associated with increased cancer risk: a survey in Italy 231
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 229
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 229
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 224
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 220
Growth hormone excess promotes breast cancer chemoresistance 217
Antiproliferative effects of somatostatin analogs in pituitary adenomas 208
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 208
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 206
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 204
Diurnal rhythm of plasma catecholamines in acromegaly 202
A new VHL polymorphism in a big family from Ferrara 200
L’iperplasia surrenale congenita e la pubertà precoce 200
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 196
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 193
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 193
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 190
Glucose metabolism alterations in acromegaly 189
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 188
In vitro testing of new somatostatin analogs on pituitary tumor cells 187
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 186
Pituitary side effects of old and new drugs. 186
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 185
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 184
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 183
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 183
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 182
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 182
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 181
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 180
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 180
ASSE GH-IGF-I NELL'INVECCHIAMENTO 179
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 179
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 178
Cerebral aneurysm and acromegaly: a case report 177
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 177
Functional hypothalamic and drug-induced amenorrhea: an overview 177
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 177
Role of the serotonergic system in the genesis of vasovagal syncope 176
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 175
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 173
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 173
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 172
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study 170
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 170
Delta opioid receptor involvement in endocrine pathophysiology 169
Le alterazioni pressorie nell'acromegalia: fattori umorali 169
Effects of pasireotide on bronchial carcinoids in primary culture 168
Sistema Simpatoadrenomidollare nei pazienti acromegalici 168
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 167
PATOLOGIA CEREBRALE ACQUISITA ED IPOPITUITARISMO 165
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 163
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 163
Replacement therapy and quality of life improvement in adult GHD patients 161
Cerebrovascular disease and GH-IGF-i axis function 161
Acromegaly in the elderly patients 161
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 160
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 160
Inflammatory cytokines and neurotrophic factors correlate with pituitary function after stroke 158
Bone metastases frequency, distribution, clinical and imaging characteristics in neuroendocrine tumors: our experience 158
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 157
Predictors of morbidity and mortality in acromegaly: An Italian survey 157
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 155
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 154
Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy 154
Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation. 154
Efficay and safety of teriparatide treatment 152
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study 152
Follow-up dei pazienti sottoposti a terapia chirurgica per adenomi ipofisari non secernenti. 151
Craniopharyngioma and Eating Disorders 151
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 150
Role of GH-IGF-1 excess on periodontal tissues 150
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 149
Prevalence of hypopituitarismin patients with cerebrovascular diseases 148
Clinica e diagnostica dei tumori neuroendocrini 148
Human galanin reduces plasma norepinephrine levels in man 147
Systemic illness 146
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 146
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 146
INVECCHIAMENTO E GH 144
Differential effects of deltorphin on arginine and galanin-induced growth hormone secretion in healthy man. 142
Successful treatment with everolimus of functioning liver metastases from a pancreatic insulinoma 142
RELIABILITY OF QUANTITATIVE ULTRASOUND IN THE FOLLOW-UP OF ADULTS WITH GH DEFICIENCY UNDERGOING REPLACEMENT THERAPY 140
Long-term low-dose tolvaptan efficacy and safety in SIADH 139
La terapia dei tumori neuroendocrini. 138
Tumori neuroendocrini: i meccanismi fisiopatologici 138
BENEFICIAL EFFECT OF GH REPLACEMENT ON COGNITIVE FUNCTIONING IN A PATIENT WITH POST-TRAUMATIC HYPOPITUITARISM 138
Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation 137
FISIOPATOLOGIA, CLASSIFICAZIONE, PATOGENESI (ACROMEGALIA) 137
Occurrence of pituitary dysfunction following traumatic brain injury 136
Evaluation of NEP-SCORE Applicability in a Series of Patients with IV Stage NEN 136
Totale 17.934
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 15.185
Totale 129.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.351 0 139 90 60 55 58 48 61 42 120 118 560
2022/20231.527 155 136 52 203 207 230 74 114 214 16 69 57
2023/2024834 68 95 50 25 51 176 25 79 25 24 24 192
2024/20253.452 99 76 267 106 419 359 129 131 579 428 483 376
2025/202610.059 939 384 800 1.162 1.615 631 1.178 535 892 1.140 479 304
2026/2027722 361 361 0 0 0 0 0 0 0 0 0 0
Totale 25.480